Althea Group has partnered with Canadian licensed producer Rocket Factory for the new range. Pic: via Getty Images.
Health & Biotech
Special Report: Althea Group has launched its new medicinal cannabis dried flower range, Atmos by Althea, in partnership with Canadian licensed producer Rocket Factory, in Australia and the UK.
The medicinal cannabis dried flower market can be segmented by the ratios of THC and CBD, and the company recognises the growth and demand in this market lies within the mid-THC and high-THC segments.
Althea Group (ASX:AGH) will initially launch two products targeting these segments – Althea Cosmic T-25 and Althea Blast T-18.
Althea Cosmic T-25 originates from Wedding Pie x Grape Pie, an indica hybrid strain known for its earthy, herbal, vanilla cake-like aroma, and is 25% THC.
Althea Blast T-18 originates from Banana OG x Ice Cream Cake, an indica hybrid strain known for its sweet and cake-like, banana aroma, and is 18% THC.
The plan is to release additional products in the new range in the future .
The new GMP-certified products combine Althea’s unrivalled experience in the medicinal cannabis industry with Rocket Factory’s state-of-the-art growing facilities and advanced cultivation techniques.
The range offers an exclusive selection of premium medicinal cannabis dried flower products cultivated on a smaller indoor scale, enabling the meticulous craft production of the highest quality cannabis offerings available.
Atmos by Althea products Image: supplied
“The launch of Atmos by Althea marks a significant milestone for Althea as we redefine the standard for medicinal cannabis dried flower products with our new Althea Cosmic T-25 and Althea Blast T-18 offerings,” AGH CEO Joshua Fegan said.
“These products set a new benchmark in the industry by delivering consistently high-quality, premium medicinal cannabis dried flowers at a competitive price point for patients.
“This initiative embodies the company’s commitment to evolving the industry, empowering healthcare professionals, and alleviating patient burdens, firmly positioning Althea at the forefront of innovation and excellence.”
This article was developed in collaboration with Althea Group, a Stockhead advertiser at the time of publishing.
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Health & Biotech
Health & Biotech
Health & Biotech
